MTOR and eosinophilia-myalgia syndrome: Administration of the mTOR inhibitor everolimus was shown to promote apoptosis and inhibit the formation of endometriotic foci, making it a potential therapeutic option for the treatment of EMs (Kacan et al., 2017).